HOME >> BIOLOGY >> NEWS
Gene analysis might explain ethnic differences in sensitivity to chemotherapy in lung cancer

DALLAS April 23, 2007 -- Analysis of three genetic mechanisms that cause non-small cell lung cancer might explain why East Asians respond better than other ethnic groups to a certain type of chemotherapy, a team led by UT Southwestern Medical Center researchers has found.

This type of analysis might become useful in tailoring cancer treatments to individual patients, the researchers said.

"Genetic differences may help explain why so many Asian women who never smoked develop lung cancer," said Dr. Adi Gazdar, professor of pathology at UT Southwestern and senior author of a study appearing online today in Public Library of Science Medicine.

The researchers focused on a protein called the epidermal growth factor receptor, or EGFR, which lies on a cells surface and is involved in controlling many processes. Excessive amounts of EGFR are known to be involved in several types of cancer, including more than half of lung cancers. Several drugs that interfere with EGFR are used as chemotherapeutic agents.

Three inherited alterations, known as polymorphisms, in the gene that codes for EGFR can cause cells to make abnormally high levels of the protein, Dr. Gazdar said. One polymorphism shortens a portion of the gene, while two other abnormalities involve variations in the genetic "alphabet," or sequences of chemical building blocks that make up the gene.

Increased levels of EGFR also can be caused by spontaneous mutations in the gene, or by an effect in tumor cells that increases the number of copies of genes coding for EGFR.

In the current study, the researchers compared the genes of 250 healthy people of various ethnicities with 556 samples of benign and cancerous lung tumors. They found that the three inherited polymorphisms were less common in healthy people from Japan and Taiwan than in healthy people of European, African or Mexican descent.

This suggests that this population normally ma
'"/>

Contact: Aline McKenzie
aline.mckenzie@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
23-Apr-2007


Page: 1 2

Related biology news :

1. AAAS analysis finds Congress would add billions to FY 2008 R&D investment
2. Genetic analysis finds greater threat in frog-killing fungus
3. Genomic analysis uncovers new targets for HIV vaccine
4. Manchester University helps with pharaoh DNA analysis
5. UN issues analysis of global investors sustainable energy gold rush
6. Interim analysis of anti-cancer vaccine, BiovaxID, to be conducted
7. New NIST reference material for peptide analysis
8. New system for soil analysis
9. DNA analysis suggests under-reported kills of threatened whales
10. DOE JGI sets gold standard for metagenomic data analysis
11. DNA sieve -- Nanoscale pores can be tiny analysis labs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 20, 2020 , ... NDA Partners Chairman Carl ... executive with expertise in clinical trial planning and feasibility, regulatory inspection readiness, and ... Throughout his career, Mr. Movahhed has helped design and manage oncology, neurology, cardiovascular, ...
(Date:8/7/2020)... ... August 06, 2020 , ... Nine middle school teachers from ... Program, a unique professional development program that provides advanced STEM (science, technology, engineering ... teachers nationwide. , Created in partnership between the National Stem Cell Foundation and ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski ... with a near term focus on Type 2 diabetes and associated comorbidities. , ... multiple therapeutic areas and classes. As Chief Commercial Officer, Justin will lead ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... , ... July 29, 2020 , ... ... solid-state radar transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, ... that can drive one or two switches in a push-pull configuration; yielding fast ...
(Date:7/31/2020)... , ... July 30, 2020 ... ... cloud-based software for the life sciences industry, today announced the release of ... designed specifically for Medical Science Liaisons (MSLs) and other field medical professionals. ...
(Date:7/18/2020)... ... 17, 2020 , ... dicentra , a leading Contract ... industries, is pleased to announce that Charles Galea has joined its clinical trials ... is an accomplished and results-driven sales executive with over 10 years of expertise ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now ... up to 200 million stem cells. Depending on the patient's condition, treatment may be ... US will die having some form of Alzheimers dementia, and the incidence continues to ...
Breaking Biology Technology:
Cached News: